Higher adiposity in infancy associated with recurrent wheeze in a prospective cohort of children

Elsie M Taveras1, Sheryl L Rifas-Shiman, Carlos A Camargo

  • 1Obesity Prevention Program, Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA. Elsie_Taveras@hphc.org

Insights

Infants with higher weight-for-length (WFL) z scores at 6 months had increased odds of recurrent wheezing by age 3. Early interventions for infant adiposity may reduce asthma symptoms in children.

Area of Science:

  • Pediatric Health
  • Respiratory Medicine
  • Epidemiology

Background:

  • Limited prospective data exist on the link between early childhood adiposity and asthma symptoms.
  • Childhood obesity is a growing public health concern with potential long-term health implications.

Purpose of the Study:

  • To investigate the association between weight-for-length (WFL) z scores at 6 months of age and the incidence of wheezing by age 3 years.
  • To explore the relationship between early adiposity and subsequent respiratory symptoms in infants.

Main Methods:

  • A prospective cohort study of 932 children was conducted.
  • Recurrent wheezing was defined as parental report of wheezing between 2-3 years plus wheezing in years 1 or 2.
  • Multiple logistic regression analysis was used to assess the association of 6-month WFL z scores with wheezing outcomes.

Main Results:

  • A higher WFL z score at 6 months was associated with increased odds of recurrent wheezing (OR, 1.46) and any wheezing (OR, 1.23) by age 3.
  • Each 1-unit increase in 6-month WFL z score correlated with a 46% greater odds of recurrent wheezing.
  • A weaker association was observed between 6-month WFL z score and current asthma.

Conclusions:

  • Higher infant adiposity, indicated by WFL z scores at 6 months, is linked to a greater risk of recurrent wheezing by age 3.
  • Findings suggest that early interventions targeting infant adiposity may be beneficial in reducing the risk of asthma-related symptoms.
  • Further research is needed to understand the long-term implications for allergic asthma and persistent wheeze.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
311
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
73
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77